(Q33890397)

English

Goserelin acetate with or without antiandrogen or estrogen in the treatment of patients with advanced prostate cancer: a multicenter, randomized, controlled trial in Japan. Zoladex Study Group

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Goserelin acetate with or without antiandrogen or estrogen in the treatment of patients with advanced prostate cancer: a multicenter, randomized, controlled trial in Japan. Zoladex Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

multicenter clinical trial

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Kotake T

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Usami M

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Akaza H

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Koiso K

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Homma Y

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kawabe K

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Aso Y

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Orikasa S

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Shimazaki J

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Isaka S

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Yoshida O

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Hirao Y

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Okajima E

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Naito S

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kumazawa J

15

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kanetake H

16

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Saito Y

17

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Ohi Y

18

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Ohashi Y

19

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Japanese Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

562-570

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

Long-term efficacy and safety of nilutamide plus castration in advanced prostate cancer, and the significance of early prostate specific antigen normalization. International Anandron Study Group

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

Evaluation of total versus partial androgen blockade in the treatment of advanced prostatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer. The Italian Prostatic Cancer Project (PONCAP) Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

Long-term results of Danish Prostatic Cancer Group trial 86. Goserelin acetate plus flutamide versus orchiectomy in advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

Efficacy of the combination of nilutamide plus orchidectomy in patients with metastatic prostatic cancer. A meta-analysis of seven randomized double-blind trials (1056 patients).

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

Bicalutamide in the Treatment of Advanced Prostatic Carcinoma: A Phase II Noncomparative Multicenter Trial Evaluating Safety, Efficacy and Long-Term Endocrine Effects of Monotherapy

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

The importance of prognostic factors in the interpretation of two EORTC metastatic prostate cancer trials. European Organization for Research and Treatment of Cancer (EORTC) Genito-Urinary Tract Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2F29.11.562

21 January 2018

Identifiers

10.1093/JJCO/29.11.562

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33890397&oldid=1966885072"